AACR Immuno-Oncology Conference
Conference Focus
Immuno-oncology research. KOL identification opportunity.
Overview
The AACR Immuno-Oncology Conference is a premier scientific gathering organized by the American Association for Cancer Research. It serves as a critical forum for the exchange of cutting-edge research in the rapidly evolving field of cancer immunology. The conference bridges the gap between basic science and clinical application, focusing on the development of novel immunotherapies, checkpoint inhibitors, and combination strategies. It is highly significant for the pharma and biotech industry as it showcases emerging data that often dictates future therapeutic pipelines and clinical trial designs. The event is unique for its rigorous scientific focus, bringing together leading academic researchers, industry scientists, and clinicians. It covers the entire spectrum of immuno-oncology, from preclinical discovery and translational research to late-stage clinical trial results, providing a comprehensive view of the current landscape and future directions in cancer treatment.
Why Attend
Pharma and biotech professionals should attend to gain early insights into transformative clinical data and emerging therapeutic targets. It offers unparalleled networking opportunities with global Key Opinion Leaders (KOLs) and academic pioneers. Attendees can evaluate competitive intelligence, identify potential collaboration partners, and understand the latest regulatory trends, providing strategic value for R&D, clinical operations, and medical affairs teams.
Key Topics & Sessions
- •Checkpoint Blockade Therapy
- •CAR T-cell and Cell Therapies
- •Tumor Microenvironment Modulation
- •Combination Immunotherapy Strategies
- •Biomarkers for Response and Resistance
- •Cancer Vaccines and Neoantigens
- •Bispecific Antibodies and Engagers
- •Translational Immuno-oncology
- •Clinical Trial Design and Endpoints
- •Next-Generation Sequencing and Diagnostics
Who Should Attend
Conference History
The American Association for Cancer Research (AACR) was founded in 1907 and is the oldest and largest cancer research organization in the world. The AACR Immuno-Oncology Conference series was established to provide a dedicated, high-impact platform for this rapidly expanding field, consistently growing in attendance and influence as immunotherapy has become a cornerstone of modern cancer care.
Venue & Location
Los Angeles, CA. Venue details are typically finalized and announced on the official conference website closer to the event date.
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About AACR Immuno-Oncology Conference
AACR Immuno-Oncology Conference is a in-person event scheduled for 2026-02-18 to 2026-02-21 in Los Angeles, CA. The conference focuses on immuno-oncology research. kol identification opportunity.. This event is categorized under Medical Affairs, Clinical Operations in our conference directory.
The AACR Immuno-Oncology Conference is a premier scientific gathering organized by the American Association for Cancer Research. It serves as a critical forum for the exchange of cutting-edge research in the rapidly evolving field of cancer immunology. The conference bridges the gap between basic science and clinical application, focusing on the development of novel immunotherapies, checkpoint inhibitors, and combination strategies. It is highly significant for the pharma and biotech industry as it showcases emerging data that often dictates future therapeutic pipelines and clinical trial designs. The event is unique for its rigorous scientific focus, bringing together leading academic researchers, industry scientists, and clinicians. It covers the entire spectrum of immuno-oncology, from preclinical discovery and translational research to late-stage clinical trial results, providing a comprehensive view of the current landscape and future directions in cancer treatment.
Professionals attending conferences like AACR Immuno-Oncology Conference gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.